Scientific critical review of clinical trials: is the objectivity important?
https://doi.org/10.21508/1027-4065-2020-65-1-105-109
Abstract
In 2016, a multicenter double-blind placebo-controlled randomized clinical trial in parallel groups was completed in the Russian Federation to evaluate the efficacy of the liquid dosage form of Anaferon for children in the treatment of acute respiratory viral infections in children. The design and main results of the study are presented in the largest foreign database ClinicalTrials. gov of the National Library of Medicine of the USA. In November 2018, the collection of reports of the XIII Russian Scientific and Practical Conference with international participation “Health is the basis of human potential: problems and solutions” published the article of the Russian chemist N.N. Khromov-Borisov, where the author questions the reliability of the study of the liquid form of Anaferon for children. The presented article analyzes the legitimacy of the author’s claims. From the point of view of statistics, the analysis of N.N. Khromov-Borisov cannot be considered objective and correct, since it contains gross methodological errors.
About the Authors
B. M. Blokhin
Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
V. V. Nikiforov
Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Разрешение на проведение клинического исследования [РКИ] №734 лекарственного препарата Анаферон детский от 24.12.2014. Реестр разрешений на проведение клинических исследований [РКИ] Государственного реестра лекарственных средств. [Clinical trial permit [RCT] No. 734 of Anaferon for children dated 24.12.2014. Register of clinical trial permits [RCT] of the State register of medicines (in Russ.)] http://grls.rosminzdrav.ru/CIPermissionMini.aspx?CIStatementGUID=e39e57c4-9d81-44db-9d70-08ed777bc9d7&CIPermGUID=A338518B-060F-4C9C-A911-7 EFA1F7650FC (ссылка активна на 17.09.2019).
2. https://clinicaltrials.gov/ct2/show/NCT03162458?сond=NCT03162458&rank=1 (ссылка активна на 17.09.2019).
3. Блохин Б.М., Шамшева О.В., Черная Н.Л., Ситников И.Г., Лазарева С.Г., Бальцерович Н.Б. и др. Результаты многоцентрового двойного слепого плацебо-контролируемого исследования применения жидкой формы Анаферона детского в лечении острых респираторных инфекций верхних дыхательных путей. Российский вестник перинатологии и педиатрии 2019; 64(4): 105–113. [Blo- khin B.M., Shamsheva O.V., Chernaya N.L., Sitnikov I.G., Lazareva S.G. et al. Results of a multicentre double-blind placebo-controlled randomized trial of the liquid form of Anaferon for children in the treatment of acute upper respiratory tract infections. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2019; 64(4): 105–113. (in Russ.) DOI: 10.21508/1027-40652019-64-4-105-113
4. Хромов-Борисов Н.Н. Статистический анализ РКИ жидкой лекарственной формы анаферона детского. Здоровье – основа человеческого потенциала: проблемы и пути их решения. СПб, 2018; 13(1): 395–400. [Khromov-Borisov N.N. Statistical analysis of RCT of liquid dosage form of Anaferon. “ Health is the basis of human potential: problems and solutions”. SPB, 2018; 13(1): 395–400. (in Russ.)]
5. Информационное письмо Центра экологии и эпидемиологии гриппа, Национального центра по гриппу ВОЗ, Института вирусологии им. Д.И. Ивановского ФГБУ «НИЦЭМ им. Н.Ф. Гамалеи» Минздрава России «О заболеваемости гриппом и ОРВИ в России и мире в эпидемическом сезоне 2018–2019 гг. (с 40 недели 2018 г. по 25 неделю 2019 г.)». [Information letter from National Influenza Center. D.I. Ivanovsky Institute of Virology FSBI “N.F.Gamaleya NRCEM” MoH, Moscow, Russia «The incidence of influenza and ARVI in Russia and the world in the epidemic season epidemic season 2018–2019 (from 40 weeks of 2018 to 25 weeks of 2019.)» (in Russ.)] http://www.gamaleya.org/index.php/2018-02-09-05-35-28/701 (ссылка активна на 18.10.2019).
6. ICH harmonised tripartite guideline. Statistical principles for clinical trials E9. https://www.ich.org/fileadmin/Public_ Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/ E9_Guideline.pdf (ссылка активна на 18.10.2019).
7. Hoenig J., Heisey D. The Abuse of Power: The Pervasive Fallacy of Power Calculations for Data Analysis. The American Statistician 2001; 55: 19–24. DOI: 10.1198/000313001300339897. http://www.vims.edu/people/hoenig_jm/pubs/hoenig2.pdf (ссылка активна на 18.10.2019).
8. Hinkley D. On the Ratio of Two Correlated Normal Random Variables. Biometrika 1969; 6(3): 635–639. DOI: 10.2307/2334671
Review
For citations:
Blokhin B.M., Nikiforov V.V. Scientific critical review of clinical trials: is the objectivity important? Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2020;65(1):105-109. (In Russ.) https://doi.org/10.21508/1027-4065-2020-65-1-105-109
Views:
1048
Email this article 